双水平正压通气联合雾化吸入在高龄患者慢性阻塞性肺疾病急性加重期合并Ⅱ型呼吸衰竭治疗中的应用

刘芳英; 钱叶长; 危蕾; 申燕华; 马伟; 王众福; 张善芳

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

双水平正压通气联合雾化吸入在高龄患者慢性阻塞性肺疾病急性加重期合并Ⅱ型呼吸衰竭治疗中的应用

刘芳英 , 钱叶长 , 危蕾 , 申燕华 , 马伟 , 王众福 , 张善芳

文章导航 > 蚌埠医学院学报 > 2014, 38 > 2: (195-201)

引用本文:

Citation:

双水平正压通气联合雾化吸入在高龄患者慢性阻塞性肺疾病急性加重期合并Ⅱ型呼吸衰竭治疗中的应用

1.
上海市宝山区中西医结合医院肺病科, 201900

作者简介: 刘芳英(1979- ),女，主治医师.

通讯作者: 钱叶长, qianyechang@163. com ;

基金项目:

Bi-level positive airway pressure respirator combined with aerosolization inhalation for the treatment of acute exacerbation of chronic obstructive pulmonary disease accompanied by type Ⅱ respiratory failure in the elderly

1.
Department of Respiratory Medicine, The Traditional Chinese and Western Medicine Hospital of Baoshan, Shanghai 201900, China

Corresponding author: Qian Yechang, qianyechang@163. com ;

摘要: 目的：观察双水平气道正压通气(BiPAP)联合雾化吸入特普他林及布地奈德治疗高龄患者慢性阻塞性肺疾病急性加重期(AECOPD)合并Ⅱ型呼吸衰竭的临床疗效。方法：将68例AECOPD合并Ⅱ型呼吸衰竭高龄患者随机分为对照组33例,观察组35例。对照组给予常规治疗,包括抗感染、解痉平喘、应用BiPAP治疗等。观察组在对照组治疗基础上联合雾化吸入特普他林及布地奈德。比较2组治疗前及治疗后1周临床症状、血气分析的变化及住院时间。结果:2组患者治疗后临床症状、血气分析均较治疗前改善(P;0.05~P0.01),观察组住院时间少于对照组(P0.01)。结论：BiPAP联合雾化吸入特普他林与布地奈德治疗高龄患者AECOPD合并Ⅱ型呼吸衰竭具有良好的临床效果。
- 肺疾病 /
- 阻塞性 /
- 呼吸衰竭 /
- 正压通气 /
- 特普他林 /
- 布地奈德 /
- 雾化吸入
Abstract: Objective: To explore the clinical effect of bi-level positive airway pressure (BiPAP ) respiraObjective: Tor combined with aerosolization inhalation in the treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD) accompanied by type Ⅱ respiraObjective: Tory failure. Methods: Sixty-eight elderly patients with AECOPD accompanied by type Ⅱ respiraObjective: Tory failure were randomly divided inObjective: To control group(33 cases) and experiment group(35 cases). The control group were given the routine therapy such as antibiotics，cleaning the airway and BiPAP ventilaObjective: Tor，and the experiment group were given inhalation of terbutaline sulfate and budesonide in addition. The changes of the clinical manifestation， arterial blood gas analysis before and after treatmen， and the time of hospital stay were compared between the two groups. Results: The clinical manifestation and blood gas analysis of the two groups improved significantly after the therapy(P ＜ 0. 05 Objective: To P ＜ 0. 01) ; the average hospital stay of the experiment group was much shorter than that of the control group(P ＜ 0. 01). Conclusions: BiPAP ventilation combined with aerosolization inhalation is effective on elderly patients with AECOPD accompanied by type Ⅱ respiraObjective: Tory failure.
- lung diseases，obstructive /
- respiratory insufficiency /
- noninvasive ventilation /
- positive pressure /
- terbutaline /
- budesonide /
- aerosol inhalation

[1]	Hilker R，Poetter C，Findeisen N，et al.Nosocomial pneumoniaafter acute stroke: implications for neurological intensive caremedicine[J].Stroke，2003，34(4) : 975 - 981.
[2] Katzan IL，Dawson NV，Thomas CL， et al.The cost of pneumoniaafter acute stroke[J].Neurology，2007，68(22) : 1938 - 1943.
[3] Pugin J，Auckenthaler R，Mili N，et al.Diagnosis of ventilatorassociated pneumonia by bacteriologic analysis of bronchoscopicand nonbronchoscopic blind bronchoalveolar lavage fluid[J].AmRev Respir Dis，1991，143(5 Pt 1) : 1121 - 1129.
[4] Upadya A，Thorevska N，Sena KN，et al.Predictors andconsequences of pneumonia in critically ill patients with stroke[J].J Crit Care，2004，19(1) : 16 - 22.
[5] Luna CM，Blanzaco D，Niederman MS，et al.Resolution ofventilator-associated pneumonia: prospective evaluation of theclinical pulmonary infection score as an early clinical predictor ofoutcome[J].Crit Care Med，2003，31(3) : 676 - 682.
[6] Emsley HC，Hopkins SJ.Acute ischaemic stroke and infection:recent and emerging concepts[J].Lancet Neurol，2008，7 (4) :341 - 353.
[7] Sui R，Zhang L.Risk factors of stroke-associated pneumonia inChinese patients[J].Neurological Research，2011，33(5) : 508 -513.
[8] Rosbolt MB，Sterling ES，Fahy BG.The utility of the clinicalpulmonary infection score[J].J Intensive Care Med，2009，24(1) : 26 - 34.
[9] 郭伟，张杰.卒中相关性肺炎病原菌对哌拉西林/舒巴坦等抗生素的耐药现状调查[J].中国神经免疫学和神经病学杂志，2010，17(4) : 279 - 282.
[10] Lundberg U.Stress hormones in health and illness: the roles ofwork and gender[J].Psychoneuroendocrinology，2005，30(10) :1017 - 1021.

[1]	蒋慧 , 朱林萍 , 邵乐健 . 布地奈德联合沙丁胺醇雾化吸入治疗慢性阻塞性肺疾病急性加重期的临床疗效观察. 蚌埠医学院学报, 2012, 36(11): 1312-1314.
[2]	秦永明 . 吸入用布地奈德混悬液和硫酸特布他林雾化液雾化吸入治疗慢性阻塞性肺疾病急性加重期疗效分析. 蚌埠医学院学报, 2009, 34(7): 582-584.
[3]	李盼盼 , 赵武 , 席康明 , 王强生 , 梅玮 , 刘东梅 , 尹远远 , 王红燕 . 早期雾化吸入布地奈德混悬液预防早产儿支气管肺发育不良的疗效和安全性分析. 蚌埠医学院学报, 2021, 46(6): 755-760. doi: 10.13898/j.cnki.issn.1000-2200.2021.06.013
[4]	陈贞祥 , 沈怀云 , 诸宏伟 , 董淮富 . 雾化吸入布地奈德、硫酸特布他林佐治小儿重症肺炎30例. 蚌埠医学院学报, 2011, 36(5): 467-469.
[5]	颜志军 , 李艳 , 温雪萍 , 丁梅芬 . 慢性阻塞性肺疾病患者血清环氧化酶-2和地诺前列酮浓度变化的临床意义. 蚌埠医学院学报, 2010, 35(9): 921-923.
[6]	高忠和 , 方陈 , 孙军 . 布地奈德联合沙丁胺醇雾化吸入治疗慢性阻塞性肺疾病加重期53例疗效分析. 蚌埠医学院学报, 2008, 33(4): 452-453.
[7]	钱叶长 , 危蕾 , 刘芳英 , 申燕华 , 周丽萍 . 支气管冲洗术联合无创正压通气治疗老年人慢性阻塞性肺疾病并Ⅱ型呼吸衰竭. 蚌埠医学院学报, 2011, 36(9): 964-967.
[8]	刘明文 , 刘云龙 . 有创与无创机械通气序贯疗法治疗慢性阻塞性肺疾病并发呼吸衰竭疗效观察. 蚌埠医学院学报, 2011, 36(5): 464-466.
[9]	巫绍明 , 韩旻 , 蒋玮 , 王华军 . 雾化吸入布地奈德混悬液治疗麻疹合并喉炎疗效观察. 蚌埠医学院学报, 2015, 40(3): 376-377. doi: 10.13898/j.cnki.issn.1000-2200.2015.03.028
[10]	周曦 . 布地奈德联合沙丁胺醇雾化吸入治疗支气管哮喘急性发作的临床观察. 蚌埠医学院学报, 2011, 36(8): 815-817.
[11]	伍德生 , 李殿明 , 吴晓飞 . 无创正压通气治疗慢性阻塞性肺病伴呼吸衰竭疗效观察. 蚌埠医学院学报, 2011, 36(9): 956-958.
[12]	刘洵洵 , 王佐 , 范莉莉 . 布地奈德悬液雾化吸入对新生儿呼吸机相关性肺炎的影响. 蚌埠医学院学报, 2014, 39(7): 861-863.
[13]	张金才 . 呼吸指数在慢性阻塞性肺疾病急性加重期合并呼吸衰竭治疗中的应用. 蚌埠医学院学报, 2012, 36(10): 1224-1226.
[14]	张媛媛 , 汪立 , 赵贵 , 李婷 . 急性呼吸衰竭病人创伤后应激障碍与恐惧疾病进展、ICU环境压力源的相关性研究. 蚌埠医学院学报, 2023, 48(8): 1147-1151. doi: 10.13898/j.cnki.issn.1000-2200.2023.08.029
[15]	毛国辉 . 阿奇霉素联合布地奈德混悬液与沙丁胺醇雾化吸入治疗小儿肺炎支原体肺炎疗效与安全性评价. 蚌埠医学院学报, 2017, 42(8): 1100-1102. doi: 10.13898/j.cnki.issn.1000-2200.2017.08.027
[16]	荣峰 . 有创-无创序贯式治疗慢性阻塞性肺疾病合并呼吸衰竭临床应用探讨. 蚌埠医学院学报, 2012, 36(4): 442-444.
[17]	宋红珊 . 氧气驱动雾化吸入肾上腺素治疗小儿急性喉炎的疗效观察. 蚌埠医学院学报, 2012, 36(8): 933-934.
[18]	孙礼宾 , 王亚宁 . 三联雾化吸入治疗婴幼儿毛细支气管炎疗效观察. 蚌埠医学院学报, 2008, 33(1): 81-82.
[19]	陈红 , 李芹 , 周娟 , 李锐 , 张野 . 护理干预套囊压力联合雾化吸入对继发甲状旁腺功能亢进手术病人术后咽喉部并发症效果观察. 蚌埠医学院学报, 2020, 45(4): 547-550. doi: 10.13898/j.cnki.issn.1000-2200.2020.04.033
[20]	邓衍圣 , 吴杰斌 , 郑刚 , 黄启凌 . 布地奈德联合氨溴索雾化吸入治疗儿童急性喉炎. 蚌埠医学院学报, 2011, 36(6): 608-609.

点击查看大图

计量

文章访问数: 3682
HTML全文浏览量: 342
PDF下载量: 157
被引次数: 0

双水平正压通气联合雾化吸入在高龄患者慢性阻塞性肺疾病急性加重期合并Ⅱ型呼吸衰竭治疗中的应用

通讯作者: 钱叶长, qianyechang@163. com;

作者简介: 刘芳英(1979- ),女，主治医师.

1. 上海市宝山区中西医结合医院肺病科, 201900

收稿日期: 2013-02-19
网络出版日期: 2014-02-15

基金项目:

关键词:

摘要: 目的：观察双水平气道正压通气(BiPAP)联合雾化吸入特普他林及布地奈德治疗高龄患者慢性阻塞性肺疾病急性加重期(AECOPD)合并Ⅱ型呼吸衰竭的临床疗效。方法：将68例AECOPD合并Ⅱ型呼吸衰竭高龄患者随机分为对照组33例,观察组35例。对照组给予常规治疗,包括抗感染、解痉平喘、应用BiPAP治疗等。观察组在对照组治疗基础上联合雾化吸入特普他林及布地奈德。比较2组治疗前及治疗后1周临床症状、血气分析的变化及住院时间。结果:2组患者治疗后临床症状、血气分析均较治疗前改善(P;0.05~P0.01),观察组住院时间少于对照组(P0.01)。结论：BiPAP联合雾化吸入特普他林与布地奈德治疗高龄患者AECOPD合并Ⅱ型呼吸衰竭具有良好的临床效果。

English Abstract

Bi-level positive airway pressure respirator combined with aerosolization inhalation for the treatment of acute exacerbation of chronic obstructive pulmonary disease accompanied by type Ⅱ respiratory failure in the elderly

Corresponding author: Qian Yechang, qianyechang@163. com

1. Department of Respiratory Medicine, The Traditional Chinese and Western Medicine Hospital of Baoshan, Shanghai 201900, China

Received Date: 2013-02-19
Available Online: 2014-02-15

Abstract: Objective: To explore the clinical effect of bi-level positive airway pressure (BiPAP ) respiraObjective: Tor combined with aerosolization inhalation in the treatment of elderly patients with acute exacerbation of chronic obstructive pulmonary disease(AECOPD) accompanied by type Ⅱ respiraObjective: Tory failure. Methods: Sixty-eight elderly patients with AECOPD accompanied by type Ⅱ respiraObjective: Tory failure were randomly divided inObjective: To control group(33 cases) and experiment group(35 cases). The control group were given the routine therapy such as antibiotics，cleaning the airway and BiPAP ventilaObjective: Tor，and the experiment group were given inhalation of terbutaline sulfate and budesonide in addition. The changes of the clinical manifestation， arterial blood gas analysis before and after treatmen， and the time of hospital stay were compared between the two groups. Results: The clinical manifestation and blood gas analysis of the two groups improved significantly after the therapy(P ＜ 0. 05 Objective: To P ＜ 0. 01) ; the average hospital stay of the experiment group was much shorter than that of the control group(P ＜ 0. 01). Conclusions: BiPAP ventilation combined with aerosolization inhalation is effective on elderly patients with AECOPD accompanied by type Ⅱ respiraObjective: Tory failure.